Long-term Follow-up of Opicapone Use as Add-on to Levodopa in Parkinson’s Patients Without Motor Fluctuations: Findings from the EPSILON Study (P7-5.027)
To assess the long-term effect of opicapone (OPC) in enhancing the clinical benefit of oral Levodopa therapy in Parkinson’s Disease (PD) patients without motor complications.
Authors
- Helena C. Brigas (ORCID: https://orcid.org/0000-0002-4176-6649)
- Fabrizio Stocchi (ORCID: https://orcid.org/0000-0002-5763-0033)
- Angelo Antonini (ORCID: https://orcid.org/0000-0003-1040-2807)
- Werner Poewe (ORCID: https://orcid.org/0000-0003-4367-0971)
- Joaquim Ferreira
- Ghazal Banisadr (ORCID: https://orcid.org/0000-0002-5678-2094)
- José‐Francisco Rocha (ORCID: https://orcid.org/0000-0003-2611-4850)
- Guillermo Castilla‐Fernández
- Olivier Rascol
- Joerg Holenz
- Paloma Lapuente
Institutions
- University of Lisbon (PT)
- Innsbruck Medical University (AT)
- Inserm (FR)
- Universität Innsbruck (AT)
- Amneal (India) (IN)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- French Clinical Research Infrastructure Network (FR)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000210477
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00